0001359824-17-000005.txt : 20170103
0001359824-17-000005.hdr.sgml : 20170103
20170103162704
ACCESSION NUMBER: 0001359824-17-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161230
FILED AS OF DATE: 20170103
DATE AS OF CHANGE: 20170103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arno Therapeutics, Inc
CENTRAL INDEX KEY: 0001195116
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522286452
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ROUTE 31 NORTH
STREET 2: SUITE 104
CITY: FLEMINGTON
STATE: NJ
ZIP: 08822
BUSINESS PHONE: (862) 703-7175
MAIL ADDRESS:
STREET 1: 200 ROUTE 31 NORTH
STREET 2: SUITE 104
CITY: FLEMINGTON
STATE: NJ
ZIP: 08822
FORMER COMPANY:
FORMER CONFORMED NAME: LAURIER INTERNATIONAL INC
DATE OF NAME CHANGE: 20021001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SUSSMAN S DONALD
CENTRAL INDEX KEY: 0001044734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52153
FILM NUMBER: 17502118
MAIL ADDRESS:
STREET 1: 217 COMMECIAL STREET
STREET 2: 5TH FLOOR
CITY: PORTLAND
STATE: ME
ZIP: 04101
4
1
form4.xml
X0306
4
2016-12-30
0001195116
Arno Therapeutics, Inc
ARNI
0001044734
SUSSMAN S DONALD
888 E. LAS OLAS BLVD.
SUITE 210
FT LAUDERDALE
FL
33301
true
See Footnote 1
Common Stock
2016-12-30
4
S
0
4285111
D
714285
D
2016 Series F Warrants (right to buy)
0.4375
2016-08-15
2021-08-15
Common Stock
357142
357142
D
2012 Series A Warrants
1.14
2016-12-30
4
S
0
1605809
D
2013-10-29
2017-11-26
Common Stock
1605809
0
D
2013 Series D Warrants
1.75
2016-12-30
4
S
0
1383702
D
2013-10-29
2018-10-29
Common Stock
1383702
0
D
Commercial Street Capital LLC ("CSC") has a contractual right to designate one member of the Issuer's board of directors and has designated Steven B. Ruchefsky, a director of the Issuer, pursuant to such right. Accordingly, the Reporting Person, as a co-managing director of CSC, may be deemed to be a director by deputization for purposes of Section 16 of the Exchange Act.
These shares of common stock or warrants exercisable for shares of common stock, as applicable, represent a pro rata distribution from CSC, and not a purchase or sale, of such shares or warrants by CSC to its members without consideration.
These reported securities are included within a sale by the Reporting Person of all such securities for an aggregate price of $1,000.
As a result of the Issuer's 8/15/16 private placement of common stock and Series F Warrants, the exercise prices and shares underlying the 2012 Series A Warrants and 2013 Series D Warrants were automatically adjusted to the exercise price and shares reflected pursuant to anti-dilution adjustment provisions in such warrants.
/s/S. Donald Sussman
2016-12-30